> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Public Meeting on Autism Drug Development
- URL: https://www.fdaweb.com/public-meeting-on-autism-drug-development/
- Published: 2017-03-06T12:00:00.000Z
- Updated: 2026-09-14T22:09:58.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138128

*Federal Register* Notice: FDA has announced a 5/4 public meeting and an opportunity for public comment on Patient-Focused Drug Development for autism. The meeting is part of FDA’s performance commitments agreed to under the Prescription Drug User Fee Act (PDUFA V). It is intended to allow FDA to obtain patient perspectives on the impact of autism on daily life as well as patient views on treatment approaches for autism. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-03-06/pdf/2017-04229.pdf?ref=fdaweb.com).